Matthew T. Wiley Bio Xcel Therapeutics, Inc. (BTAI) insider trading activity

BTAI Quotes by TradingView

Matthew T. Wiley is Chief Commercial Officer of BioXcel Therapeutics, Inc.. Currently has a direct ownership of 4,033 shares of BTAI, which is worth approximately $2,581. The most recent transaction as insider was on Sep 16, 2024, when has been sold 215 shares (Common Stock) at a price of $0.69 per share, resulting in proceeds of $148. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.03K
15.29% 3M change
n/a 12M change
Total Value Held $2,581

Matthew T. Wiley Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 16 2024
SELL
Open market or private sale
$148 $0.69 p/Share
215 Reduced 5.06%
4,033 Common Stock
Sep 15 2024
BUY
Exercise of conversion of derivative security
-
750 Added 15.01%
4,248 Common Stock
Jun 17 2024
SELL
Open market or private sale
$307 $1.26 p/Share
244 Reduced 6.52%
3,498 Common Stock
Jun 15 2024
BUY
Exercise of conversion of derivative security
-
750 Added 16.7%
3,742 Common Stock
Apr 04 2024
SELL
Open market or private sale
$2,661 $2.64 p/Share
1,008 Reduced 25.2%
2,992 Common Stock
Mar 15 2024
BUY
Exercise of conversion of derivative security
-
3,000 Added 50.0%
3,000 Common Stock

Also insider at

VYNE
VYNE Therapeutics Inc. Healthcare
Chief Commercial Officer
MTW

Matthew T. Wiley

Chief Commercial Officer
Bridgewater, NJ

Track Institutional and Insider Activities on BTAI

Follow BioXcel Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BTAI shares.

Notify only if

Insider Trading

Get notified when an Bio Xcel Therapeutics, Inc. insider buys or sells BTAI shares.

Notify only if

News

Receive news related to BioXcel Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BTAI